Diagnostic and prognostic significance of circulating HPV cfDNA in cervical cancer: A systematic review and meta-analysis
Open Access
- 29 January 2026
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 220, 105161
Abstract
No abstract availableKeywords
Funding Information
- Council of Scientific and Industrial Research, India
This publication has 43 references indexed in Scilit:
- Gene‐specific ctDNA dynamics predict tumour burden and survival outcomes in ESCC: A prospective cohort studyClinical and Translational Medicine, 2025
- Prognostic value of human papillomavirus cell-free DNA in cervical cancer patients: A systematic review and meta-analysisEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2024
- Circulating cell‐free HPV DNA is a strong marker for disease severity in cervical cancerMolecular Oncology, 2023
- HPV Circulating Cell-Free DNA Kinetics in Cervical Cancer Patients Undergoing Definitive ChemoradiationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2023
- Digital droplet PCR-based quantification of ccfHPV-DNA as liquid biopsy in HPV-driven cervical and vulvar cancerJournal of Cancer Research and Clinical Oncology, 2023
- HPV ctDNA detection of high-risk HPV types during chemoradiotherapy for locally advanced cervical cancerESMO Open, 2021
- Liquid biopsy of HPV DNA in cervical cancerJournal of Clinical Virology, 2019
- Cell-free DNA in maternal plasma and serum: A comparison of quantity, quality and tissue origin using genomic and epigenomic approachesClinical Biochemistry, 2016
- Circulating human papillomavirus DNA detected using droplet digital PCR in the serum of patients diagnosed with early stage human papillomavirus‐associated invasive carcinomaThe Journal of Pathology: Clinical Research, 2016
- The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessedJournal of Clinical Epidemiology, 2005